Skip to main content

Comera Life Sciences Holdings, Inc.

CMRADelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001907685

Comera Life Sciences Holdings, Inc. was delisted in 2026; its insiders filed their last Form 4 on Feb 2, 2024; no institution reported holding it in 13F filings for Q1 2026; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
0
Q1 2026
13F value
$0
Reported value at the end of Q1 2026
Superinvestors holding
0
At the end of Q1 2026

Superinvestors holding CMRA, Q1 2026

Go to the superinvestors tab

No superinvestor reported holding CMRA at the end of Q1 2026.

Latest insider trades

Open-market purchases and sales by Comera Life Sciences Holdings, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 2, 2024 (view filing)7:48 PM ETDec 29, 202335 daysLateKonar Shameek and 1 otherOther: Member of 10% owner groupPPurchase+6.14M$0.00$0–4.09M afterDerivative2 lotsPrice outlier
Jan 11, 2024 (view filing)7:14 PM ETDec 29, 202313 daysLateDenny George P IIIOther: Member of 10% owner groupPPurchase+5.87M$0.00$0–3.91M afterDerivative2 lotsPrice outlier
Jan 5, 2024 (view filing)5:59 PM ETDec 29, 20237 daysLateIaf, LLCOther: Member of 10% owner groupPPurchase+11.5M$0.00$0–7.64M afterDerivative2 lotsPrice outlier
Jan 3, 2024 (view filing)8:38 PM ETDec 29, 20235 daysCherington Charles10% OwnerPPurchase+31.0M$0.00$0–20.7M afterDerivative2 lotsPrice outlier
Jan 3, 2024 (view filing)8:38 PM ETDec 27, 20237 daysLateCherington Charles10% OwnerPPurchase+310.2K$6,280.01+$1.95B–3.90K afterDerivativePrice outlier
Jan 3, 2024 (view filing)8:09 PM ETDec 29, 20235 daysHuff Curtis W and 2 others10% OwnerPPurchaseCommon Stock, par value $0.0001 per share+7.36M$0.055+$134.9K–7.36M afterDerivative2 lots
Jan 3, 2024 (view filing)6:30 PM ETDec 29, 20235 daysSoane David and 1 other10% OwnerPPurchase+8.18M$25,000.00+$204.5B–2.73M afterDerivative4 lotsPrice outlier
Nov 28, 2023 (view filing)4:25 PM ETNov 271 dayCampbell Michael GerardEVP & CFOPPurchase+10.0K$0.0708+$708+40.0%35.0K after
Sep 12, 2023 (view filing)4:52 PM ETSep 111 daySoane David and 1 other10% OwnerPPurchase+117.4K$0.5112+$60.0K+70.3%284.3K after2 lots
Sep 12, 2023 (view filing)4:52 PM ETSep 111 daySoane David and 1 other10% OwnerPPurchase+293.4K$0.00$0–146.7K afterDerivative2 lots

Top 10 13F holders, Q1 2026

The largest institutional positions in Comera Life Sciences Holdings, Inc. at the end of Q1 2026; share changes are against Q4 2025.

View all: Top 10 13F holders, Q1 2026

No institution reported holding CMRA in 13F filings for Q1 2026.